BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8972475)

  • 21. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
    Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
    Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
    Mori M; Chiba R; Takahashi T
    Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
    Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
    Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
    Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T; Lindgren A
    Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
    Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative study of the precancerous and malignant lesions in colorectal adenomas.
    Ranaldi R; Bearzi I; Santinelli A; Mannello B; Mariuzzi GM
    Pathol Res Pract; 1992 Jun; 188(4-5):561-4. PubMed ID: 1409089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
    Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
    Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
    Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
    Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
    Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
    Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
    Lopez-Beltran A; Qian J; Montironi R; Luque RJ; Bostwick DG
    Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
    Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
    PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung.
    Kodama T; Biyajima S; Watanabe S; Shimosato Y
    Am J Clin Pathol; 1986 Feb; 85(2):146-51. PubMed ID: 3946300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
    Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
    Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung.
    Cooper CA; Carby FA; Bubb VJ; Lamb D; Kerr KM; Wyllie AH
    J Pathol; 1997 Apr; 181(4):401-4. PubMed ID: 9196437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
    Cheng L; Shan A; Cheville JC; Qian J; Bostwick DG
    Cancer Res; 1998 Feb; 58(3):389-91. PubMed ID: 9458077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.